8-KThe WireRoutine
Bylaw Amendment · Company Update
Filed Jan 10, 2025 · 1y ago · Accession 0001193125-25-004443
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Rein Therapeutics, Inc.
- Ticker
- RNTX
- CIK
- 1420565
- Form type
- 8-K
- Filing date
- Jan 10, 2025
- Report date
- Jan 10, 2025
- Document
- d898488d8k.htm
- Size
- 289 KB